Find clinical trials for Kidney Disease in Toronto, ON

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases

Chronic Renal Insufficiency

Chronic Kidney Failure

Renal Insufficiency

IGA Glomerulonephritis

Renal Cell Carcinoma

Carcinoma

Kidney Disease trials near Toronto, ON, CAN:

Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK)

administering low dose rivaroxaban to reduce the risk of major adverse cardiac event (MACE) in people with Chronic Kidney Disease ...

Enrolling

Chronic Kidney Diseases

Dialysis-dependent Kidney Failure

Drug: Rivaroxaban 2.5 Mg Oral Tablet

Other: Placebo

Phase 3

The George Institute

Hamilton, Canada and 82 other locations

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD)

We are doing this study to learn more about how tirzepatide may help fight chronic kidney disease in people with obesity with or wi...

Enrolling

Chronic Kidney Disease

Overweight

Drug: Placebo

Drug: Tirzepatide

Phase 2

Lilly

Toronto, Ontario, Canada and 27 other locations

A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)

We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. W...

Active, not recruiting

Chronic Kidney Disease

Diabetes Mellitus, Type 2

Drug: Placebo (Semaglutide)

Drug: Semaglutide

Phase 3

Novo Nordisk

Toronto, Ontario, Canada and 32 other locations

A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys...

Enrolling

Chronic Kidney Diseases

Type 2 Diabetes Mellitus

Biological: Renal Autologous Cell Therapy (REACT)

Procedure: Sham Comparator

Phase 3

Prokidney

Oshawa, Ontario, Canada and 45 other locations

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease (AMPLITUDE)

tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...

Enrolling

Proteinuric Kidney Disease

Drug: Placebo

Drug: VX-147

Phase 2, Phase 3

Vertex Pharmaceuticals

Toronto, Canada and 243 other locations

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes (FINE-ONE)

Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...

Enrolling

Chronic Kidney Disease

Type 1 Diabetes Mellitus

Other: Placebo

Drug: Finerenone

Phase 3

Bayer

Toronto, Canada and 80 other locations

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2...

Enrolling

Chronic Kidney Disease

Obesity

Drug: Placebo

Drug: Cagrilintide

Phase 2

Novo Nordisk

Toronto, Ontario, Canada and 106 other locations

Locations recently updated

ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...

Enrolling

Chronic Kidney Disease

Cardiac Disease

Drug: Placebo

Drug: Ravulizumab

Phase 3

Alexion Pharmaceuticals

Toronto, Ontario, Canada and 178 other locations

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes (CONFIDENCE)

receptor is known to trigger injury and inflammation in the kidney and is therefore thought to play a role in CKD.Empagliflozin lowers blood...

Enrolling

Chronic Kidney Disease

Type 2 Diabetes Mellitus

Drug: Finerenone (BAY94-8862 ) 20 mg

Drug: Finerenone Placebo

Phase 2

Bayer

Toronto, Ontario, Canada and 210 other locations

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria (FIONA OLE)

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling

Chronic Kidney Disease

Proteinuria

Drug: Finerenone (Kerendia, BAY94-8862)

Phase 3

Bayer

Toronto, Ontario, Canada and 146 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Kidney Disease in .css-epvm6{white-space:nowrap;}Toronto, ON

Related conditions:

Kidney Disease trials near Toronto, ON, CAN:

Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK)

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD)

A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)

A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease (AMPLITUDE)

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes (FINE-ONE)

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes (CONFIDENCE)

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria (FIONA OLE)

Find clinical trials for Kidney Disease in Toronto, ON